Microglial activation and chronic neurodegeneration.

Department of Anatomy and Neurobiology, Virginia Commonwealth University Medical Campus, Richmond, Virginia 23298, USA.
Journal of the American Society for Experimental NeuroTherapeutics (Impact Factor: 3.88). 10/2010; 7(4):354-65. DOI: 10.1016/j.nurt.2010.05.014
Source: PubMed

ABSTRACT Microglia, the resident innate immune cells in the brain, have long been implicated in the pathology of neurodegenerative diseases. Accumulating evidence points to activated microglia as a chronic source of multiple neurotoxic factors, including tumor necrosis factor-α, nitric oxide, interleukin-1β, and reactive oxygen species (ROS), driving progressive neuron damage. Microglia can become chronically activated by either a single stimulus (e.g., lipopolysaccharide or neuron damage) or multiple stimuli exposures to result in cumulative neuronal loss with time. Although the mechanisms driving these phenomena are just beginning to be understood, reactive microgliosis (the microglial response to neuron damage) and ROS have been implicated as key mechanisms of chronic and neurotoxic microglial activation, particularly in the case of Parkinson's disease. We review the mechanisms of neurotoxicity associated with chronic microglial activation and discuss the role of neuronal death and microglial ROS driving the chronic and toxic microglial phenotype.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurodegenerative diseases are characterized by the loss of specific neuronal populations. Epidemiological studies and pathologycal analyses have demonstrated the existence of a link between mutations in specific genes and heritable forms of neurodegenerative diseases. Although some of these mutations can be found in higher frequency among certain ethnic populations, together they account for only a small percentage of all cases. Therefore, at the present it is well accepted that the causes of idiopathic or non-familial forms of neurodegenerative diseases are multifactorial, including genetic predisposition, epigenetic factors, age, and even environmental factors. Although the key molecular and cellular events underlying the development of neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's and multiple sclerosis, are clearly different, a common feature between them is neuroinflammation. In this context, the central nervous system has long been considered to be an immuneprivileged site because of the presence of the blood–brain barrier and the lack of a lymphatic system, still it is now well established that it is fully capable of mounting an inflammatory response. Invading pathogens, trauma, stroke, intraneural as well as extracellular fibrillary material can trigger local invasion of circulating immune cells, production of reactive oxygen and nitrogen species, as well as the activation of the brain resident macrophages known as microglia. Inflammation in the central nervous system has been appropriately described as a two-edged sword; in acute situations inflammatory mechanisms limit injury and promotes healing; however, in a chronic situation neuroinflammation can seriously damage viable host tissue. Current studies support the notion that neuroinflammation promotes or facilitates neurodegeneration; therefore, early intervention with antiinflammatory therapies in populations identified to be at risk due to genetic mutations may represent a valuable tool. We present recent data regarding non-genetic mechanisms that regulate the development of neurological disorders including Huntington’s disease, multiple sclerosis, Parkinson’s disease and Alzheimer’s disease.
    Molecular Aspects of Inflammation, 11/2013: chapter Neurodegenerative disorders and inflammation: pages 173-207; Research Signpost., ISBN: 978-81-308-0528-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: The marine environment is a rich source of materials with significant biological activities. Isolation and investigation of bioactive materials from marine organisms is a topic of current research interest in the food industry. Among marine-derived bioactive materials, peptides, chitosan, sulfated polysaccharides, phlorotannins, and natural pigments are potential neuroprotective agents. This review elaborates on the neuroprotective mechanisms of marine-derived bioactive materials and emphasizes prospects for use in neuroprotection as part of nutraceuticals and functional foods.
    Food science and biotechnology 10/2013; 22(5):1-12. DOI:10.1007/s10068-013-0200-z · 0.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Honey is a natural product produced by bees and has been used for thousands of years as a medicinal agent and dietary supplement. It is known to cure a wide variety of ailments and can be used as a potent anti-inflammatory and wound healing agent. These vital bioactivities of honey are far less well known than its antibacterial, antioxidant, and any other biological activities. Many clinical trials have been reported and revealed that, when honey is applied to wound, there is a decrease in inflammation and will have a soothing effect. There is much evidence for the anti-inflammatory and wound healing effects of honey in terms of publications in modern medical and scientific journals. The exact mechanism of anti-inflammatory activity and wound healing property of honey has yet to be demonstrated. Possibly there are several mechanisms of action. There are also some reports where honey exerts negligible side effects. The article focuses on the components of honey involved in its anti-inflammatory effect, possible mechanism of action, properties of honey responsible for its wound healing activity, and its adverse effects. Overall the review presents the evidence and explanation for the anti-inflammatory and wound healing properties of honey.
    European Food Research and Technology 12/2014; 239(6):1003-1014. DOI:10.1007/s00217-014-2297-6 · 1.39 Impact Factor

Full-text (2 Sources)

Available from
Jun 6, 2014